297 related articles for article (PubMed ID: 29399290)
1. Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase.
Hayashi M; Kawana S; Sekino H; Abe K; Matsuoka N; Kashiwagi M; Okai K; Kanno Y; Takahashi A; Ito H; Hashimoto Y; Ohira H
World J Hepatol; 2018 Jan; 10(1):166-171. PubMed ID: 29399290
[TBL] [Abstract][Full Text] [Related]
2. Co-registered positron emission tomography/computed tomography and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging features of multiple angiosarcoma of the liver.
Kamatani T; Iguchi H; Okada T; Yamazaki H; Tsunoda H; Watanabe M; Oda M; Ohbu M; Yokomori H
Hepatol Res; 2014 Oct; 44(10):E297-303. PubMed ID: 24147907
[TBL] [Abstract][Full Text] [Related]
3. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
Lin CY; Chang WC; Chou CT; Chen RC
J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
[TBL] [Abstract][Full Text] [Related]
4. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis.
Takeyama Y; Tsuchiya N; Kunimoto H; Fukunaga A; Sakurai K; Hirano G; Yokoyama K; Morihara D; Anan A; Irie M; Shakado S; Sohda T; Sakisaka S
Hepatol Res; 2015 Oct; 45(10):E108-14. PubMed ID: 25560223
[TBL] [Abstract][Full Text] [Related]
6. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
7. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB
World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082
[TBL] [Abstract][Full Text] [Related]
8. Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging.
Miyaaki H; Ichikawa T; Taura N; Miuma S; Kawaguchi M; Kohno R; Isomoto H; Takeshima F; Nakashima O; Nakao K
Clin J Gastroenterol; 2011 Aug; 4(4):266-272. PubMed ID: 26189532
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
[TBL] [Abstract][Full Text] [Related]
10. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of carcinosarcoma of the liver using Gd-EOB-DTPA.
Yasutake T; Kiryu S; Akai H; Watadani T; Akahane M; Tomizawa N; Gonoi W; Ikemura M; Takahashi M; Matsuoka Y; Ohtomo K
Magn Reson Med Sci; 2014; 13(2):117-21. PubMed ID: 24769633
[TBL] [Abstract][Full Text] [Related]
13. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
[TBL] [Abstract][Full Text] [Related]
14. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
[TBL] [Abstract][Full Text] [Related]
15. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
[TBL] [Abstract][Full Text] [Related]
16. Effect of body mass index (BMI) on image contrast in the hepatobiliary phase of Gd-EOB-DTPA-enhanced-MRI and the feasibility of the application of half-dose Gd-EOB-DTPA to hepatobiliary phase imaging in patients with a BMI less than 24: a comparative study.
Chen R; Lu Y; Xiao Z; Zhang Z; Lv F; Lv F
Quant Imaging Med Surg; 2023 Sep; 13(9):6176-6192. PubMed ID: 37711824
[TBL] [Abstract][Full Text] [Related]
17. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.
Channual S; Pahwa A; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503
[TBL] [Abstract][Full Text] [Related]
18. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
[TBL] [Abstract][Full Text] [Related]
19. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
[TBL] [Abstract][Full Text] [Related]
20. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
